Intended for healthcare professionals


Review of decision to restrict meningitis B vaccine to babies will report in summer

BMJ 2016; 352 doi: (Published 24 March 2016) Cite this as: BMJ 2016;352:i1735
  1. Adrian O’Dowd
  1. London

An expert group set up to review the methodology behind the United Kingdom’s decision to restrict access to the meningitis B vaccine to infants under 1 year old will report its findings in June, MPs have been told.

MPs on the health and petitions committees questioned experts and scientists on 22 March as part of their inquiry into an online petition that called for all children to be given the meningitis B vaccine up to at least age 11. The petition received a record breaking 823 342 signatures.

Infants aged under 1 have been eligible for the vaccine since September 2015, after an abbreviated schedule brought …

View Full Text

Log in

Log in through your institution


* For online subscription